What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.21%Above 5Y avg (0.18%)
Annual Rate
CNY 0.03Paid annual
Payout Ratio
42.9%Sustainable
Last Ex-Dividend
Jun 15, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.77BCNY
565.14M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
191.57x
vs Health Information Services peers
Updated Oct 21, 2026
Revenue (TTM)
433.88MCNY
65.03M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
4.51%
vs Health Information Services peers
Updated Oct 21, 2026
Beta
0.5190x
vs all stocks
Updated Oct 21, 2026
52-Week Change
16.67%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
3.77BCNY
565.14M · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
3.10BCNY
465.35M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
191.57x
vs Health Information Services peers
Updated Oct 21, 2026
Price to Sales (TTM)
8.12x
vs Health Information Services peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 8.69×.Updated Oct 21, 2026
Price to Book (MRQ)
3.17x
vs Health Information Services peers
Updated Oct 21, 2026
Enterprise to Revenue
7.16x
vs Health Information Services peers
Updated Oct 21, 2026
Enterprise to EBITDA
125.45x
vs Health Information Services peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 26.37×.Updated Oct 21, 2026
Gross Margin
24.26%
vs Health Information Services peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 41.44%.Updated Oct 21, 2026
Profit Margin
4.51%
vs Health Information Services peers
Updated Oct 21, 2026
Operating Margin
-37.39%
vs Health Information Services peers
Updated Oct 21, 2026
Return on Assets (TTM)
0.90%
vs Health Information Services peers
Updated Oct 21, 2026
Return on Equity (TTM)
2.09%
vs Health Information Services peers
Updated Oct 21, 2026
Revenue (TTM)
433.88MCNY
65.03M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
1.97CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
1.50%
vs Health Information Services peers
Updated Oct 21, 2026
Gross Profit (TTM)
179.81MCNY
26.95M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
117.74MCNY
17.65M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
19.58MCNY
2.94M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
4.20%
vs Health Information Services peers
Updated Oct 21, 2026
Operating Cash Flow (TTM)
120.44MCNY
18.05M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
87.07MCNY
13.05M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing Annual Dividend Rate
0.0300CNYUpdated Oct 21, 2026
Trailing Annual Dividend Yield
0.21%
vs all stocks
Updated Oct 21, 2026
5-Year Average Dividend Yield
0.18%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
42.86%
vs Health Information Services peers
Updated Oct 21, 2026
Minority Interest (Equity)
26.65MCNYFY2025 · Dec 31, 2025
Revenue
435.06MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
232.16MCNYFY2025 · Dec 31, 2025
Gross Profit
202.89MCNYFY2025 · Dec 31, 2025
Operating Income
84.30MCNY
12.64M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
50.14MCNYFY2025 · Dec 31, 2025
Income Tax Expense
2.13MCNYFY2025 · Dec 31, 2025
Net Income
48.01MCNYFY2025 · Dec 31, 2025
EBIT
52.44MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
117.74MCNYFY2025 · Dec 31, 2025
Research & Development
53.10MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
19.02MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
6.64MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
5.30MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
2.31MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.1800CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1800CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
264.80MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
264.80MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
48.01MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-344.01KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
56.80MCNYFY2025 · Dec 31, 2025
Free Cash Flow
14.94MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
528.08MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
48.01MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
11.77MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
7.39MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-10.36MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-41.87MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-1.14MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-580.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
541.70MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-81.31MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
50.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-96.00MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-8.87MCNYFY2025 · Dec 31, 2025
Other Financing Charges
17.81KCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-54.85MCNYFY2025 · Dec 31, 2025
Shares Outstanding
262.56MSharesUpdated Oct 21, 2026
Float Shares
145.84MSharesUpdated Oct 21, 2026
% Held by Insiders
56.47%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
1.08%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
448.39MCNY
67.21M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
1.71CNYUpdated Oct 21, 2026
Total Debt (MRQ)
1.98MCNY
296.35K · vs all stocks (USD)
Updated Oct 21, 2026
Current Ratio (MRQ)
4.14x
vs Health Information Services peers
Updated Oct 21, 2026
Book Value per Share (MRQ)
4.24CNYUpdated Oct 21, 2026
Total Assets
1.50BCNY
224.53M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.20BCNYFY2025 · Dec 31, 2025
Total Liabilities
319.51MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
299.26MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.51MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
318.00MCNYFY2025 · Dec 31, 2025
Cash
527.53MCNYFY2025 · Dec 31, 2025
Cash Equivalents
5.41MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
532.94MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
60.06MCNYFY2025 · Dec 31, 2025
Accounts Receivable
294.13MCNYFY2025 · Dec 31, 2025
Inventory
23.25MCNYFY2025 · Dec 31, 2025
Accounts Payable
221.13MCNYFY2025 · Dec 31, 2025
Short-term Debt
51.19MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
2.29MCNYFY2025 · Dec 31, 2025
Long-term Debt
790.94KCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
719.28KCNYFY2025 · Dec 31, 2025
Common Stock (Book)
262.56MCNYFY2025 · Dec 31, 2025
Retained Earnings
240.83MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.18BCNY
176.64M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
9.83CNYUpdated Oct 21, 2026
52-Week High
16.95CNYUpdated Oct 21, 2026
52-Week Change
16.67%
vs all stocks
Updated Oct 21, 2026
Beta
0.5190x
vs all stocks
Updated Oct 21, 2026
50-Day MA
13.31CNYUpdated Oct 21, 2026
200-Day MA
13.39CNYUpdated Oct 21, 2026
Avg 10-Day Volume
5.92MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
7.29MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
0.0700CNYUpdated Oct 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 24.3%, lower than 95% of its Health Information Services peers (median 61.2%)Significant